Dystonia and reflex sympathetic dystrophy induced by ergotamine

Mov Disord. 1991;6(3):263-4. doi: 10.1002/mds.870060313.

Abstract

A 59-year-old man developed dystonia and reflex sympathetic dystrophy after receiving high doses of ergotamine for migraine treatment. Ischemia is suggested as the precipitating factor.

Publication types

  • Case Reports

MeSH terms

  • Dystonia / chemically induced*
  • Dystonia / diagnosis
  • Dystonia / physiopathology
  • Ergotamine / administration & dosage
  • Ergotamine / adverse effects*
  • Foot / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Migraine Disorders / drug therapy
  • Reflex Sympathetic Dystrophy / chemically induced*
  • Reflex Sympathetic Dystrophy / diagnosis
  • Reflex Sympathetic Dystrophy / physiopathology

Substances

  • Ergotamine